HNF1A recruits UTX to activate a differentiation program that suppresses pancreatic cancer
Mark KalisziD, Edgar BernardoiD, Anthony BeucheriD, Miguel Angel Maestro, Natalia del PozoiD, I.R. Hernández MillániD, Lena HäberleiD, Martin Schlensog, Sami Alexander SafiiD, Wolfram Trudo KnoefeliD, Vanessa Grau, Matías G. De Vas, Karl B. ShpargeliD, Eva Cristina VaqueroiD, Terry MagnusoniD, Sagrario OrtegaiD, Iréne EspositoiD, Francisco X. RealiD, Jorge P. FerreriD
Abstract
Defects in transcriptional regulators of pancreatic exocrine differentiation have been implicated in pancreatic tumorigenesis, but the molecular mechanisms are poorly understood. The locus encoding the transcription factor HNF1A harbors susceptibility variants for pancreatic ductal adenocarcinoma (PDAC), while KDM6A, encoding the histone demethylase UTX, carries somatic mutations in PDAC. Here, we show that pancreas-specific Hnf1a null mutations phenocopy Utx deficient mutations, and both synergize with KrasG12D to cause PDAC with sarcomatoid features. We combine genetic, epigenomic and biochemical studies to show that HNF1A recruits UTX to genomic binding sites in pancreatic acinar cells. This remodels the acinar enhancer landscape, activates a differentiation program, and indirectly suppresses oncogenic and epithelial-mesenchymal transition genes. Finally, we identify a subset of non-classical PDAC samples that exhibit the HNF1A/UTX-deficient molecular phenotype. These findings provide direct genetic evidence that HNF1A-deficiency promotes PDAC. They also connect the tumor suppressive role of UTX deficiency with a cell-specific molecular mechanism that underlies PDAC subtype definition.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 77
- FWCI
- 3.79
- Field percentile
- top 5%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HNF1A is a Novel Oncogene and Central Regulator of Pancreatic Cancer Stem Cells
E. Abel, M. Goto, … D. M. Simeone·bioRxiv·Dec 22, 2017
- Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4
S. A. Camolotto, V. Belova, … E. Snyder·bioRxiv·Oct 22, 2019
- HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma
Kennedy S. Humphrey, Katherine J. Crawford, … Ethan V. Abel·Communications BiologyPeer-reviewed·Jul 30, 2026
- Targeting FGFR4 Abrogates HNF1A-driven Metastasis in Pancreatic Ductal Adenocarcinoma
Katherine J. Crawford, Kennedy S. Humphrey, … Ethan V. Abel·Molecular CancerPeer-reviewed·Jul 29, 2025
- Regulation of HDAC2-PDX1 by RNF125 defines pancreatic cancer development
E. Hasnis, H. Kim, … Z. A. Ronai·bioRxiv·Jan 6, 2020
- NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer
J. Doffo, S. A. Bamopoulos, … M. Wirth·bioRxiv·Oct 21, 2021